Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Completed Phase 1 Trials for Tretinoin (DB00755)

IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00217412Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaTreatment